MS in the News: Pregnancy, Brain Atrophy, Tysabri News, and much more

If you are having trouble viewing this message, please Click Here     WEEK OF: October 27, 2011    THIS e-Newsletter is being received in (88) Countries  PLEASE click this link which directs you to our blog. PLEASE BOOKMARK or get the RSS feed for this site as You will be amazed at all the information found there.   ===================================  In This Week's issue:  LOTS and LOTS of New MS Research Studies on oral medications, PML, Brain Atrophy, Pregnancy and MS, MRI updates, Optic Neuritis, FDA news and more...  ~~~~~~~~~~~~~~~~~~~~~~~~~~ StuMSRadio and MSLOL have JOINED and our New Name for Blog Talk Radio will be known as Multiple Sclerosis-Unplugged  ~~~~~~~~~~~~~~~~~~~~~~~~~~    EVER have the need to  Contact your MS  Pharmaceutical company and cannot remember where you stored the phone number?    No need to worry. Just look at any of our e-Newsletters Scroll to the bottom of the page to find the information for each of the Disease Modifying Medications (DMS's)       ~~~~~~~~~~~~~~~~~~~~~~~~~~   Find us on Facebook at:  facebook.com/msviewsandnews    "Providing You with 'MS Views and News', IS What We Do" _______________________________ Please donate to assure that 'MS Views and News'  will  continue to provide educational resources for those affected by Multiple Sclerosis We are a 501©(3) organization as recognized by the Internal Revenue Service.   Your Donation IS Tax Deductible to the Fullest extent permitted by law.  .........................       "CLICK"   to View our Sponsor banners    on our website  .....................................    ~~~~~~~~~~~~~~~~~~~~      Over 120,000 have 'Liked'  our blog. Have you?  Click HERE     ~~~~~~~~~~~~~~~~~~~          On the Fourth Wednesday of Each Month Visit: StuMSradio   With Deanna and Stu  CLICK:                                                    Multiple Sclerosis-Unplugged  http://www.blogtalkradio.com/multiplesclerosis-unplugged * OR Call (347) 215-9265 *  To listen, speak with us or speak with a guest    ===================================================      ~~  MS in the News  ~~  Review this week's (19) articles:     Exposure to MS Drugs During Pregnancy: What is best.. See, hear or do. What’s your favorite way to learn... Synergy Develops Registry To Advance Research on . Stopping natalizumab (Tysabri) to take a medicatio... Cognitive Decline, Brain Atrophy More Rapid for Me... ^^^^^^^^^^^^^^^^^^^^^^^^^^^^   Multiple sclerosis diagnosis turned her life upsid... In study, Lemtrada helps MS patients One of the scientists at Biogen Idec pushing for a... Genentech announces 96-week results from ocrelizum. Clinical and MRI Outcomes in Patients With MS, Tr... ^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Approximately One-Third of MS Patients Experiencin... Natalizumab (Tysabri)-Associated PML Survival Rate.. Athersys has entered a partnership with a nonprofi... Optic Neuritis - The definition SURVEY FINDS MAJORITY OF PEOPLE WITH MS.. ^^^^^^^^^^^^^^^^^^^^^^^^^^^^ The U.S. Food & Drug Administration (FDA) has acc. About BG-12 - Possibly the Next Oral MS medication.. Biogen's Oral BG-12 (Dimethyl Fumarate) Significan.. 2011 ECTRIMS Symposium ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Help Us to Educate the World with MS Views and News  by providing a small Donation - thank you    ~~~~~~~~~~~~~~~~~~   BID ON VACATIONS and other goods VISIT Our auction page:  www.biddingforgood.com/msviewsandnews   ~~~~~~~~~~~~~~~~~~  Visit the MS Views and News WEBSITE - CLICK HERE    - to see our sponsor banners and logos - Learn what you can when visiting this  MS Resources link,  provided by MS Views and News  ~~~~~~~~~~~~~~~~~~ MISSED a Podcast?   See Our Podcast Video Archives by clicking: www.youtube.com/msviewsandnews                                                    <><><><><><><><><><><><>  <><><><><><><><><><><><>      Skype Name:  ms.views.and.news       ===================================================    SOCIAL MEDIA and Other Learning Methods                             Find us on  Facebook at our  primary page: facebook.com/msviewsandnews  FACEBOOK CHAT ROOMS For All Affected by MS, Click: http://goo.gl/S3oO    For Caregivers, Click: http://goo.gl/b1GVr   For the Patient with a progressive form of MS, Click: http://goo.gl/1MnI8    LOOK for Stuart on Facebook: facebook.com/stuart.schlossman   JOIN "Friends of 'Stu's Views and MS News" - a FaceBook Chat Room for anybody WITH or affected BY, Multiple Sclerosis: http://goo.gl/S3oO -See more facebook links below.   ======================================== Pharmaceutical-Patient Resources Avonex - MS ActiveSource (800) 456-2255 www.avonex.com ---------------------Betaseron - Betaplus MS Support (800) 788-1467 www.betaseron.com ---------------------Copaxone - Shared Solutions (800) 887-8100 www.sharedsolutions.com ---------------------Extavia - Patient Support (866) 925-2333 www.extavia.com ---------------------Gilenya - Patient Support (877) 408-4974 www.gilenya.com ---------------------Rebif  - MS LifeLines (877) 447-3243 www.MSLifeLines.com  ---------------------Novantrone - (877) 447-3243 www.novantrone.com ---------------------Tysabri -TOUCH  Program (800) 456-2255 www.tysabri.com    ========================================================  ==================== Visit Our Blog, Bookmark the website and review each week's informational M.S. postings by Clicking here  ==================   SHARE OUR WEBSITE and BLOG Facebook and Twitter  information and Website addresses (URL's)   WITH OTHERS  ================ TIME and Effort are put into each week's  e-newsletters and podcast series.    Please share the information we provide to educate and inform, with others.       Sponsors for this e-Newsletter and our podcast series, have been provided by:                        ================================       OUR MISSION:  'MS Views and News' (MSVN)  is dedicated to the global collection and distribution of current information concerning Multiple Sclerosis.  In collaboration with other organizations, 'MS Views and News' uses state-of-the-art communication channels to provide information for those affected by, or interested in MS. -Newsletter Disclaimer: ***Editor's Note: The intent of this newsletter is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.